EUVIMEDEUVIMED entdecken
Crossref

Urine Choline Oxidation Metabolites Predict Chronic Kidney Disease Progression in Patients With Type 2 Diabetes

Jian-Jun Liu iD, Sylvia Liu, Resham L Gurung iD, Janus Lee, Huili Zheng, Keven Ang, Clara Chan, Lye Siang Lee, Sharon Han, Jean-Paul Kovalik, Jianhong Ching, Pierre-Jean Saulnier und 3 weitere

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Jian-Jun Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Khoo Teck Puat Hospital, Singapore 768828, Singapore. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Choline, Renal Insufficiency, Chronic, Diabetic Nephropathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: KTPH STAR, Singapore National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Choline is metabolized in kidney tubules but the relationship between choline metabolism and kidney disease has not been systematically characterized.

Objective

To study whether urine metabolites in the choline oxidation pathway may predict the risk of chronic kidney disease (CKD) progression in individuals with type 2 diabetes.

Methods

Outpatients (n = 1894) with type 2 diabetes were recruited from a secondary hospital and a primary care facility. Urine choline, betaine, dimethylglycine, and sarcosine were measured by liquid chromatography–mass spectrometry. CKD progression was defined as a composite of incident end-stage kidney disease (sustained eGFR <15 mL/min/1.73m2, maintenance dialysis, renal death) and doubling of serum creatinine.

Results

CKD progression occurred in 263 participants during a median follow-up of 9.2 years. High levels of urine choline and dimethylglycine were associated with an increased risk of CKD progression after adjustment for clinical risk factors (adjusted HR [95% CI], 1.32 [1.16-1.51] and 1.30 [1.14-1.47], respectively, per 1 SD). Urine choline and dimethylglycine were positively correlated with tubulopathy biomarkers, especially dickkopf-related protein 3 (dkk3, Spearman rho 0.55 and 0.53). The association between dkk3 and CKD progression was diminished but the association between choline, dimethylglycine, and CKD progression remained significant after mutual adjustments. Choline and dimethylglycine were also independently associated with risk of all-cause death (adjusted HR 1.20 [1.06-1.37] and 1.17 [1.04-1.33], respectively).

Conclusion

Urine choline and dimethylglycine independently predict the risk of CKD progression in individuals with type 2 diabetes. Dysregulation of intrarenal choline metabolism may be involved in tubulopathy leading to progressive loss of kidney function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2CholineRenal Insufficiency, ChronicDiabetic NephropathiesHumansMaleFemaleDisease ProgressionMiddle AgedAgedBiomarkersSarcosineOxidation-ReductionFollow-Up StudiesPrognosisBetaine

Stichwörter der Autor:innen

all-cause mortalitycholinediabetic kidney diseasedimethylglycineend-stage kidney diseasetubulopathy

Substanzen

CholineBiomarkersSarcosinedimethylglycineBetaine

Autor:innen und Institutionen

  • Clinical Research Unit, Khoo Teck Puat Hospital, Singapore 768828, Singapore.
  • Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore 169857, Singapore.
  • CHU Poitiers Clinical Investigation Center CIC 1402, University of Poitiers, INSERM, Poitiers 86000, France.
  • L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, Nantes 44007, France.
  • Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117549, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.

ORCID-Profile: Jian-Jun Liu, Resham L Gurung, Su Chi Lim

Förderung

  • KTPH STAR
  • Singapore National Medical Research Council

Zitieren

APA

Liu, J. J., Liu, S., Gurung, R. L., Lee, J., Zheng, H., Ang, K., Chan, C., Lee, L. S., Han, S., Kovalik, J. P., Ching, J., Saulnier, P. J., Hadjadj, S., Coffman, T. M., & Lim, S. C. (2025). Urine Choline Oxidation Metabolites Predict Chronic Kidney Disease Progression in Patients With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf281

Vancouver

Liu JJ, Liu S, Gurung RL, Lee J, Zheng H, Ang K, et al. Urine Choline Oxidation Metabolites Predict Chronic Kidney Disease Progression in Patients With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf281

BibTeX
@article{Liu2025,
  author = {Liu, Jian-Jun and Liu, Sylvia and Gurung, Resham L and Lee, Janus and Zheng, Huili and Ang, Keven and Chan, Clara and Lee, Lye Siang and Han, Sharon and Kovalik, Jean-Paul and Ching, Jianhong and Saulnier, Pierre-Jean and Hadjadj, Samy and Coffman, Thomas M and Lim, Su Chi},
  title = {Urine Choline Oxidation Metabolites Predict Chronic Kidney Disease Progression in Patients With Type 2 Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf281}
}
Kostenlos starten →